Replimune Group Inc (REPL)
6.43
-0.29
(-4.32%)
USD |
NASDAQ |
May 17, 16:00
6.43
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Price: 6.43 for May 17, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2024 | 6.79 | 6.93 | 6.405 | 6.44 | 901503.0 |
| May 16, 2024 | 6.64 | 6.76 | 6.27 | 6.72 | 930340.0 |
| May 15, 2024 | 6.92 | 6.96 | 6.72 | 6.81 | 553697.0 |
| May 14, 2024 | 6.64 | 7.01 | 6.54 | 6.71 | 528023.0 |
| May 13, 2024 | 6.46 | 6.84 | 6.34 | 6.59 | 408108.0 |
| May 10, 2024 | 6.76 | 6.95 | 6.38 | 6.41 | 390601.0 |
| May 09, 2024 | 6.65 | 6.79 | 6.51 | 6.73 | 520383.0 |
| May 08, 2024 | 6.78 | 6.83 | 6.57 | 6.68 | 926015.0 |
| May 07, 2024 | 7.04 | 7.27 | 6.83 | 6.88 | 475859.0 |
| May 06, 2024 | 7.22 | 7.24 | 6.93 | 7.01 | 412090.0 |
| May 03, 2024 | 6.80 | 7.08 | 6.605 | 6.95 | 631256.0 |
| May 02, 2024 | 6.54 | 6.66 | 6.37 | 6.56 | 723317.0 |
| May 01, 2024 | 6.36 | 6.76 | 6.22 | 6.48 | 887306.0 |
| Apr 30, 2024 | 6.49 | 6.62 | 6.35 | 6.35 | 779090.0 |
| Apr 29, 2024 | 6.46 | 6.78 | 6.29 | 6.58 | 480317.0 |
| Apr 26, 2024 | 6.22 | 6.575 | 6.06 | 6.42 | 603791.0 |
| Apr 25, 2024 | 6.18 | 6.41 | 5.86 | 6.15 | 783453.0 |
| Apr 24, 2024 | 6.41 | 6.66 | 6.20 | 6.33 | 631812.0 |
| Apr 23, 2024 | 6.47 | 6.77 | 6.385 | 6.42 | 1.157M |
| Apr 22, 2024 | 6.56 | 6.669 | 6.22 | 6.42 | 551481.0 |
| Apr 19, 2024 | 6.90 | 7.07 | 6.33 | 6.45 | 866786.0 |
| Apr 18, 2024 | 7.20 | 7.43 | 6.95 | 6.97 | 1.126M |
| Apr 17, 2024 | 7.19 | 7.33 | 7.14 | 7.21 | 1.138M |
| Apr 16, 2024 | 7.01 | 7.25 | 6.92 | 7.15 | 684229.0 |
| Apr 15, 2024 | 7.14 | 7.26 | 7.07 | 7.12 | 671857.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.15
Minimum
Apr 25 2024
52.65
Maximum
Dec 01 2020
21.29
Average
19.20
Median
May 13 2020
Price Benchmarks
| Esperion Therapeutics Inc | 2.36 |
| Gossamer Bio Inc | 0.7002 |
| NovaBay Pharmaceuticals Inc | 0.1186 |
| Palatin Technologies Inc | 2.00 |
| iBio Inc | 1.98 |
Price Related Metrics
| Price to Book Value | 1.056 |
| Earnings Yield | -50.31% |
| Market Cap | 395.51M |